The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia
NACompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
July 31, 2016
Primary Completion Date
March 2, 2018
Study Completion Date
March 2, 2018
Conditions
SchizophreniaSchizoaffective DisorderAuditory Hallucination, VerbalNeurocognitive DysfunctionAutonomic ImbalancePsychosocial ImpairmentQuality of Life
Interventions
DEVICE
tDCS
Trial Locations (1)
114
Tri-service general hospital, Taipei
All Listed Sponsors
lead
Tri-Service General Hospital
OTHER
NCT03388554 - The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter